• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

Lyn­parza fails a PhI­II test in col­orec­tal can­cer, cut­ting off big R&D av­enue for Mer­ck and As­traZeneca

3 years ago
R&D
Pharma

Safe­ty scare cleared and ear­ly da­ta in hand, Ul­tragenyx dish­es out $75M to buy rare dis­ease part­ner

3 years ago
Deals

Fol­low­ing Lux­tur­na and slate of eye dis­ease ap­provals, Roche adds an­oth­er oph­thal­mol­o­gy part­ner for AAV gene ...

3 years ago
Startups
Deals

Ei­sai shut­ters on­col­o­gy unit, cuts around 80 jobs

3 years ago
Pharma

Bio­gen sees more than 330 de­par­tures from MA-based sites since last sum­mer

3 years ago
Pharma

GSK nets a deal with Cana­di­an gov­ern­ment for flu vac­cine man­u­fac­tur­ing

3 years ago
Pharma
Manufacturing

Khloé Kar­dashi­an strikes again with mi­graine med Nurtec mar­ket­ing in ‘all in one’ push

3 years ago
Pharma
Marketing

Mil­li­pore­Sig­ma us­es DOD funds to ex­pand Wis­con­sin-based man­u­fac­tur­ing site

3 years ago
Manufacturing

Phar­ma R&D spend­ing in the US more than dou­bles in a decade, PhRMA sur­vey finds

3 years ago
Pharma

Eu­rope buys 54,000 more dos­es of Bavar­i­an Nordic's mon­key­pox vac­cine as cas­es in­crease

3 years ago
Pharma

Am­gen ex­pands Sto­ryCorps on­col­o­gy cam­paign with celebri­ty ac­tor, preps for up­com­ing health eq­ui­ty sto­ries

3 years ago
Pharma
Marketing

GSK's con­sumer health unit Ha­le­on off to a rough start

3 years ago
Pharma

Black­Rock joins An­drew Lo's risk analy­sis firm to search for odds-on biotech bets in tur­bu­lent times

3 years ago
Deals
Bioregnum

Ed­i­tas hires top Sanofi sci­en­tist for CMO as C-suite shuf­fle con­tin­ues

3 years ago
R&D

Im­muno­core is the lat­est to nab a pri­vate place­ment, se­cur­ing $140M to pur­sue more TCR R&D

3 years ago
Financing

An old epilep­sy med gets oral liq­uid for­mu­la­tion nod; PMV pairs up AS­CO stand­out with Keytru­da

3 years ago
News Briefing

Weeks af­ter rare dis­ease drug got spurned, Ac­er re­turns to FDA for sec­ond shot

3 years ago
FDA+

Sesen Bio paus­es blad­der can­cer drug work, of­floads eye dis­ease an­ti­bod­ies to Roche

3 years ago
R&D

Eliem de­lays a de­pres­sion tri­al, in­def­i­nite­ly post­pones an­oth­er af­ter blam­ing CMC is­sues for low drug ex­po­sure

3 years ago
R&D

Sanofi waves the white flag on Reg­u­lus' mi­croR­NA pro­gram tar­get­ing rare kid­ney dis­ease

3 years ago
Pharma

Sam­sung’s CD­MO arm com­mits to $324M land pur­chase for a sec­ond bio cam­pus

3 years ago
Financing
Manufacturing

Ox­ford Sci­ence En­ter­pris­es col­lects $300M to of­fer spin­outs 's­cale-up cap­i­tal'

3 years ago
Financing

DNA se­quenc­ing gi­ant Il­lu­mi­na bat­tles an­titrust reg­u­la­tors and grow­ing com­pe­ti­tion

3 years ago
Pharma
In Focus

Nestlé puts down $40M, kicks off deal with gut mi­cro­bio­me spe­cial­ist to fight food al­ler­gies

3 years ago
Deals
First page Previous page 491492493494495496497 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times
Endpoints News

Confirm Profile

Endpoints News